{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T06:38:04Z","timestamp":1794465484764,"version":"4.9.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018722","name":"Jaap Schouten Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018722","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijcard.2026.134289","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:44:44Z","timestamp":1773161084000},"page":"134289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Serially measured blood biomarkers collected in the context of usual care, predict clinical outcome in a real-life heart failure population"],"prefix":"10.1016","volume":"452","author":[{"given":"Thomas F.","family":"Kok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Abou Kamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin","family":"Suthahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Wemelsfelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogier J","family":"Barendse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris","family":"Holtrop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannick A.N.","family":"Dorresteijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf A.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.A.","family":"van der Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas M.","family":"van Dalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Bruining","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Kardys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"36","key":"10.1016\/j.ijcard.2026.134289_bb0005","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"issue":"12","key":"10.1016\/j.ijcard.2026.134289_bb0010","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jacc.2008.04.069","article-title":"Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (valsartan heart failure trial)","volume":"52","author":"Masson","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"24","key":"10.1016\/j.ijcard.2026.134289_bb0015","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1161\/CIRCULATIONAHA.123.064386","article-title":"Sex differences in cardiac troponin trajectories over the life course","volume":"147","author":"de Bakker","year":"2023","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.ijcard.2026.134289_bb0020","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/01.CIR.0000144310.04433.BE","article-title":"N-terminal\u2013pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients","volume":"110","author":"Bettencourt","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ijcard.2026.134289_bb0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/CIRCULATIONAHA.107.694562","article-title":"Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time","volume":"116","author":"Miller","year":"2007","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcard.2026.134289_bb0030","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/eurjhf\/hfp003","article-title":"The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction","volume":"11","author":"Kub\u00e1nek","year":"2009","journal-title":"Eur. J. Heart Fail."},{"issue":"3","key":"10.1016\/j.ijcard.2026.134289_bb0035","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1001\/jamacardio.2022.5309","article-title":"Association of long-term change in N-terminal pro\u2013B-type natriuretic peptide with incident heart failure and death","volume":"8","author":"Jia","year":"2023","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcard.2026.134289_bb0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ahj.2017.10.008","article-title":"Toward personalized risk assessment in patients with chronic heart failure: detailed temporal patterns of NT-proBNP, troponin T, and CRP in the bio-SHiFT study","volume":"196","author":"van Boven","year":"2018","journal-title":"Am. Heart J."},{"issue":"4","key":"10.1016\/j.ijcard.2026.134289_bb0045","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.kint.2017.09.013","article-title":"Patient-specific evolution of renal function in chronic heart failure patients dynamically predicts clinical outcome in the bio-SHiFT study","volume":"93","author":"Brankovic","year":"2018","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.ijcard.2026.134289_bb0050","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/ehjdh\/ztad056","article-title":"Machine learning\u2013based biomarker profile derived from 4210 serially measured proteins predicts clinical outcome of patients with heart failure","volume":"4","author":"de Bakker","year":"2023","journal-title":"Eur. Heart J. Digit. Health"},{"issue":"8","key":"10.1016\/j.ijcard.2026.134289_bb0055","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/ejhf.749","article-title":"A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial","volume":"19","author":"Demissei","year":"2017","journal-title":"Eur. J. Heart Fail."},{"issue":"11","key":"10.1016\/j.ijcard.2026.134289_bb0060","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cardfail.2017.09.009","article-title":"Implementation of real-time assessment of patient-reported outcomes in a heart failure clinic: a feasibility study","volume":"23","author":"Stehlik","year":"2017","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2026.134289_bb0065","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijcard.2018.07.100","article-title":"Addition of routinely measured blood biomarkers significantly improves GRACE risk stratification in patients with myocardial infarction","volume":"273","author":"Van Toorenburg","year":"2018","journal-title":"Int. J. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcard.2026.134289_bb0070","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jacc.2020.11.063","article-title":"Association of NT-ProBNP, blood pressure, and cardiovascular events: the ARIC study","volume":"77","author":"Hussain","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2026.134289_bb0075","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jchf.2017.11.003","article-title":"High-sensitivity cardiac troponin and new-onset heart failure: a systematic review and meta-analysis of 67,063 patients with 4,165 incident heart failure events","volume":"6","author":"Evans","year":"2018","journal-title":"JACC Heart Fail."},{"issue":"3","key":"10.1016\/j.ijcard.2026.134289_bb0080","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ahj.2006.02.023","article-title":"C-reactive protein and risk of heart failure. The Rotterdam study","volume":"152","author":"Kardys","year":"2006","journal-title":"Am. Heart J."},{"issue":"3","key":"10.1016\/j.ijcard.2026.134289_bb0085","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cardfail.2008.10.030","article-title":"Prognostic value of high-sensitivity C-reactive protein in heart failure: a systematic review","volume":"15","author":"Ara\u00fajo","year":"2009","journal-title":"J. Card. Fail."},{"issue":"4","key":"10.1016\/j.ijcard.2026.134289_bb0090","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004675","article-title":"The potential role of NT-proBNP in screening for and predicting prognosis in heart failure: a survival analysis","volume":"4","author":"Taylor","year":"2014","journal-title":"BMJ Open"},{"issue":"22","key":"10.1016\/j.ijcard.2026.134289_bb0095","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1001\/jama.2010.1708","article-title":"Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults","volume":"304","author":"DeFilippi","year":"2010","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ijcard.2026.134289_bb0100","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/CIRCULATIONAHA.111.044149","article-title":"Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials","volume":"125","author":"Masson","year":"2012","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ijcard.2026.134289_bb0105","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1177\/2047487320922639","article-title":"Personalized screening intervals for measurement of N-terminal pro-B-type natriuretic peptide improve efficiency of prognostication in patients with chronic heart failure","volume":"28","author":"Schuurman","year":"2021","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"22","key":"10.1016\/j.ijcard.2026.134289_bb0110","doi-asserted-by":"crossref","first-page":"e1054","DOI":"10.1161\/CIR.0000000000000490","article-title":"Role of biomarkers for the prevention, assessment, and management of heart failure: a scientific statement from the American Heart Association","volume":"135","author":"Chow","year":"2017","journal-title":"Circulation"},{"issue":"9088","key":"10.1016\/j.ijcard.2026.134289_bb0115","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0140-6736(97)06031-5","article-title":"Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care","volume":"350","author":"Cowie","year":"1997","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.ijcard.2026.134289_bb0120","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/eurheartj\/ehs191","article-title":"Troponin elevation in patients with heart failure: on behalf of the third universal definition of myocardial infarction global task force: heart failure section","volume":"33","author":"Januzzi","year":"2012","journal-title":"Eur. Heart J."},{"issue":"8","key":"10.1016\/j.ijcard.2026.134289_bb0125","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.cardfail.2007.04.008","article-title":"Worsening renal function and prognosis in heart failure: systematic review and meta-analysis","volume":"13","author":"Damman","year":"2007","journal-title":"J. Card. Fail."},{"issue":"3","key":"10.1016\/j.ijcard.2026.134289_bb0130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000500409","article-title":"Are we barking up the wrong tree? Rise in serum creatinine and heart failure","volume":"48","author":"Kazory","year":"2019","journal-title":"Blood Purif."},{"issue":"7","key":"10.1016\/j.ijcard.2026.134289_bb0135","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.cardfail.2011.02.012","article-title":"Gamma-glutamyltransferase rather than total bilirubin predicts outcome in chronic heart failure","volume":"17","author":"Ess","year":"2011","journal-title":"J. Card. Fail."},{"issue":"3","key":"10.1016\/j.ijcard.2026.134289_bb0140","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/eurjhf\/hfs007","article-title":"Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial","volume":"14","author":"Ambrosy","year":"2012","journal-title":"Eur. J. Heart Fail."},{"issue":"Supplement_2","key":"10.1016\/j.ijcard.2026.134289_bb0145","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehac544.871","article-title":"Alkaline phosphatase and bilirubin combined are a powerful predictor of outcome in patients with heart failure and reduced ejection fraction: an analysis of the ATMOSPHERE and PARADIGM-HF trials","volume":"43","author":"Adamson","year":"2022","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.ijcard.2026.134289_bb0150","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/ejhf.2649","article-title":"Liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA-HF","volume":"24","author":"Adamson","year":"2022","journal-title":"Eur. J. Heart Fail."},{"issue":"5","key":"10.1016\/j.ijcard.2026.134289_bb0155","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.cardfail.2015.02.003","article-title":"The urea-to-creatinine ratio is predictive of worsening kidney function in ambulatory heart failure patients","volume":"21","author":"Sood","year":"2015","journal-title":"J. Card. Fail."},{"issue":"7","key":"10.1016\/j.ijcard.2026.134289_bb0160","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/clc.23850","article-title":"Prognostic value of RDW alone and in combination with NT-proBNP in patients with heart failure","volume":"45","author":"Liang","year":"2022","journal-title":"Clin. Cardiol."},{"issue":"10\u221212","key":"10.1016\/j.ijcard.2026.134289_bb0165","article-title":"Risk-profile based monitoring intervals for multivariate longitudinal biomarker measurements and competing events with applications in stable heart failure","volume":"44","author":"Petersen","year":"2025","journal-title":"Stat. Med."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527326001373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527326001373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T22:21:45Z","timestamp":1774045305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527326001373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":33,"alternative-id":["S0167527326001373"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2026.134289","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serially measured blood biomarkers collected in the context of usual care, predict clinical outcome in a real-life heart failure population","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2026.134289","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"134289"}}